Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The Influence of Dopamine Receptor SNPs on Substance Use Disorder in a Jordanian Cohort

ABSTRACT: A study investigating the association between dopamine receptor SNPs and substance use disorder in males

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: Jordan University of Science and Technology

PROVIDER: PRJEB89083 | EVA | 2025-05-03

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	control_variants_corrected.vcf.csi	Other
	control_variants_corrected.vcf.gz	Vcf
	control_variants_corrected.vcf.gz.csi	Vcf
	patient_variants_corrected.vcf.csi	Other
	patient_variants_corrected.vcf.gz	Vcf

Items per page:

1 - 5 of 6

Similar Datasets

Analysis of association between LPHN3 markers and substance use disorder

Project description:Analysis of association between LPHN3 markers and substance use disorder

| PRJNA448611 | ENA

GDF15 in alcohol use disorder

Project description:GDF15 in alcohol use disorder Raw sequence reads

| PRJNA1366826 | ENA

Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder

Project description:Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder

| PRJNA729134 | ENA

Effect of opioid use disorder on HIV latent reservoirs

Project description:Effect of opioid use disorder on HIV latent reservoirs

| PRJNA967476 | ENA

Effect of opioid use disorder on HIV latent reservoirs

Project description:Effect of opioid use disorder on HIV latent reservoirs

| PRJNA967477 | ENA

Methamphetamine and Other Substance Use Disorder Genetics in Thailand

Project description:Methamphetamine and Other Substance Use Disorder Genetics in Thailand

| PRJNA955367 | ENA

Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder

Project description:Epigenetic Moderators of Naltrexone Efficacy for Alcohol Use Disorder

| PRJNA729135 | ENA

Alcohol use disorder-associated DNA methylation differences in nucleus accumbens and dorsolateral prefrontal cortex

Project description:Alcohol use disorder (AUD) has a profound public health impact and understanding of the molecular mechanisms underlying the development and progression of AUD remain limited. Many genetic risk loci have been identified for AUD or alcohol consumption, though the neurobiological mechanisms underlying these loci remain largely unknown. DNA methylation (DNAm) differences between individuals with and without AUD can provide insight into the mechanisms that predispose to AUD and consequences of AUD itself. Here, we provide Illumina HumanMethylation EPIC array data generated in nucleus accumbens and dorsolateral prefrontal cortex, both addiction relevant brain tissues, from 119 decedents of European ancestry: 61 controls and 58 cases. From these data we have conducted an epigenome-wide association study (EWAS) and identified several CpG associations with AUD. A subset of the identified CpGs map to genes that were previoulsy identified as associated with substance use behaviors in genetic studies, but the other CpGs map to genes previoulsy unassociated with substance use behaviors and are novel.

2024-01-18 | GSE252501 | GEO

Intestinal virome in alcohol use disorder and abstinence

Project description:Intestinal virome in alcohol use disorder and abstinence Raw sequence reads

| PRJNA786875 | ENA

Candidate SNPs association with APOC3

Project description:ApoC-III is a proatherogenic protein associated with elevated triglycerides; its deficiency is associated with reduced atherosclerosis. Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy. We sought to identify single nucleotide polymorphisms (SNPs) associated with apoC-III level response to combination therapy with statins and fenofibric acid (FA) in individuals with mixed dyslipidemia. Participants in a multicenter, randomized, double-blind, active-controlled study examining response to FA alone and in combination with statin were genotyped for candidate SNPs. Association between genotyed SNPs and APOC3 response to therapy was conducted

2012-01-11 | GSE34945 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data